|
New clinical trial shows increased asthma control with FeNO-guided anti …
News-Medical.net A total of 187 non-smoking asthma patients (18-64 years) with perennial allergy and on regular inhaled corticosteroid (ICS) treatment were recruited at 17 primary health care centres in Sweden, randomly assigned to two groups and followed for one year. AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided … |
View full post on asthma – Google News